The National Blood Service Commission (NBSC) has partnered with Netherlands-based HemoClear BV to tackle blood transfusion shortages.
The alliance, according to a statement sent to PREMIUM TIMES on Friday, is set to introduce “autologous, a patient-own blood transfusion service, to address issues of blood shortages leading to suffering and preventable death.”
Due to the hurdles of using the existing autologous blood processing equipment for blood transfusions, the alliance aims to overcome such barriers by introducing HemoClear’s pioneering micro-filtration technology that facilitates the collection and processing of a patient’s blood during surgery.
